Use of Katakadirasanjana Eye Drop in Simple Allergic Conjuctivitis

Clinical evaluation of Katakadi eye drop in simple allergic conjuctivitis - NiL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063439

Enrollment

Registered

2024-03-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group of 16-60 yrs. 2.The patients have the signs and symptoms of simple allergic conjuctivitis like itching/redness/watering/chemosis. 3.either sex

Exclusion criteria

Exclusion criteria: 1.Patients not willing for Trial. 2.Patients suffering from Dry Eye/Blepharitis/Trichiasis/Dacrocystitis/Trachoma and Other acute and chronic diseases of eye. 3.Complicated Conjuctivitis and Conjuctival Diseases. 4.Known cases of other systematic disorders like Hypertension,Diabetes,Skin Allergy and Asthma.

Design outcomes

Primary

Measure	Time frame
Outcome will be assess on the basis of decrease in subjective parameters like 1.Redness 2.itching 3.watering 4.Chemosis 5.photophobia 6.burning sensationTimepoint: The assessment will be done on 1st,7th and after completion of the trial i.e on 15th day	—

Secondary

Measure	Time frame
Outcome will be assess on the basis of decrease in objective parameters like. 1.Palpebral Conjuctival Congestion 2.Bulbar Conjuctival Congestion 3.Absolute Eosinophils Count 4.Papillae on Palpebral aperatureTimepoint: The assessment will be done on 1st,7th and after completion of the trial i.e on 15th day	—

Countries

India

Contacts

Public ContactGARGI VERMA

Rishikul Ayurved Campus

drkhemchand.sharma@gmail.com8006945015

Outcome results